Siqi Li

914 total citations
64 papers, 591 citations indexed

About

Siqi Li is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Siqi Li has authored 64 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cardiology and Cardiovascular Medicine, 16 papers in Molecular Biology and 14 papers in Oncology. Recurrent topics in Siqi Li's work include Cancer Immunotherapy and Biomarkers (7 papers), CAR-T cell therapy research (6 papers) and Atrial Fibrillation Management and Outcomes (4 papers). Siqi Li is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), CAR-T cell therapy research (6 papers) and Atrial Fibrillation Management and Outcomes (4 papers). Siqi Li collaborates with scholars based in China, Japan and United States. Siqi Li's co-authors include Kazuko Tajiri, Masaki Ieda, Qiong Huang, Baimei He, Dongzhu Xu, Nobuyuki Murakoshi, Wenbin Nan, Kazutaka Aonuma, Zhengping Xu and Hui Peng and has published in prestigious journals such as Blood, Biomaterials and The Science of The Total Environment.

In The Last Decade

Siqi Li

53 papers receiving 589 citations

Peers

Siqi Li
Yequn Chen China
Neha Gupta India
Sema Uysal Türkiye
Surasak Kantachuvesiri Thailand
Yi-Jen Hung Taiwan
Nithya Krishnan United States
Csaba Bereczki Hungary
Mei Xue China
Aivars Lejnieks Latvia
Danyal Imani Iran
Yequn Chen China
Siqi Li
Citations per year, relative to Siqi Li Siqi Li (= 1×) peers Yequn Chen

Countries citing papers authored by Siqi Li

Since Specialization
Citations

This map shows the geographic impact of Siqi Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siqi Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siqi Li more than expected).

Fields of papers citing papers by Siqi Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Siqi Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siqi Li. The network helps show where Siqi Li may publish in the future.

Co-authorship network of co-authors of Siqi Li

This figure shows the co-authorship network connecting the top 25 collaborators of Siqi Li. A scholar is included among the top collaborators of Siqi Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Siqi Li. Siqi Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Siqi, et al.. (2025). Curcumin in colorectal cancer: mechanistic insights, pharmacological limitations, and translational perspectives. Frontiers in Pharmacology. 16. 1667731–1667731.
2.
Li, Siqi, et al.. (2025). Protective role of DsbA-L in COPD: Alleviating ER stress-induced apoptosis through AMPK activation. Environmental Pollution. 385. 127138–127138. 1 indexed citations
3.
4.
Hu, Yongwei, Wang Li, Lei Lyu, et al.. (2025). Multi-faceted nanodrug reinforcing metalloimmunotherapy for hepatocellular carcinoma. Biomaterials. 329. 123899–123899.
5.
Ling, Shaohua, Siqi Li, Lianmin Zhang, et al.. (2025). Enhancing the catalytic performance of xylanase XynASP through semi-rational design in the cord region to promote its application in juice clarification. International Journal of Biological Macromolecules. 305(Pt 1). 141138–141138. 1 indexed citations
6.
Wang, Jing, Siqi Li, Ying‐Jun Chang, et al.. (2024). Sintilimab plus decitabine for higher-risk treatment-naïve myelodysplastic syndromes: efficacy, safety, and biomarker analysis of a phase II, single-arm trial. Journal for ImmunoTherapy of Cancer. 12(11). e010355–e010355. 3 indexed citations
7.
8.
Li, Siqi, et al.. (2024). Autoantibody profiling of patients with immune checkpoint inhibitor-associated myocarditis: a pilot study. Frontiers in Immunology. 15. 1423622–1423622. 1 indexed citations
9.
10.
Li, Siqi, Qiong Huang, Wenbin Nan, & Baimei He. (2023). Association between serum phosphate and in-hospital mortality of patients with AECOPD: A retrospective analysis on eICU database. Heliyon. 9(9). e19748–e19748. 4 indexed citations
11.
Li, Siqi, Bin Zou, Lingyu Zhang, et al.. (2022). Salt-Sensitive Ileal Microbiota Plays a Role in Atrial Natriuretic Peptide Deficiency-Induced Cardiac Injury. Nutrients. 14(15). 3129–3129. 7 indexed citations
12.
Xia, Zhongyuan, et al.. (2022). Ciprofol attenuates the isoproterenol-induced oxidative damage, inflammatory response and cardiomyocyte apoptosis. Frontiers in Pharmacology. 13. 1037151–1037151. 33 indexed citations
13.
Tajiri, Kazuko, Nobuyuki Murakoshi, Dongzhu Xu, et al.. (2021). Neutrophil Elastase Deficiency Ameliorates Myocardial Injury Post Myocardial Infarction in Mice. International Journal of Molecular Sciences. 22(2). 722–722. 34 indexed citations
14.
Li, Siqi, Kazuko Tajiri, Nobuyuki Murakoshi, et al.. (2021). Programmed Death-Ligand 2 Deficiency Exacerbates Experimental Autoimmune Myocarditis in Mice. International Journal of Molecular Sciences. 22(3). 1426–1426. 13 indexed citations
15.
Tajiri, Kazuko, et al.. (2021). Immunomodulatory Role of Tenascin-C in Myocarditis and Inflammatory Cardiomyopathy. Frontiers in Immunology. 12. 624703–624703. 13 indexed citations
16.
17.
Tajiri, Kazuko, et al.. (2020). Fatal cerebral haemorrhagic infarction due to left ventricular thrombus after healing of immune checkpoint inhibitor-associated myocarditis. European Heart Journal - Case Reports. 4(4). 1–2. 5 indexed citations
18.
Li, Xiao, Yumei Que, Siqi Li, et al.. (2020). Smooth muscle NADPH oxidase 4 promotes angiotensin II-induced aortic aneurysm and atherosclerosis by regulating osteopontin. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1866(12). 165912–165912. 22 indexed citations
19.
Shen, Hua, Siqi Li, Yu Wang, & Kai‐Rong Qin. (2018). Effects of the arterial radius and the center-line velocity on the conductivity and electrical impedance of pulsatile flow in the human common carotid artery. Medical & Biological Engineering & Computing. 57(2). 441–451. 5 indexed citations
20.
Jiang, Xiaoyan, et al.. (2012). CYP7A1 polymorphism influences the LDL cholesterol-lowering response to atorvastatin. Journal of Clinical Pharmacy and Therapeutics. 37(6). 719–723. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yequn Chen Breakdown of academic impact, for papers by Neha Gupta Breakdown of academic impact, for papers by Sema Uysal Breakdown of academic impact, for papers by Surasak Kantachuvesiri Breakdown of academic impact, for papers by Yi-Jen Hung Breakdown of academic impact, for papers by Nithya Krishnan Breakdown of academic impact, for papers by Csaba Bereczki Breakdown of academic impact, for papers by Mei Xue Breakdown of academic impact, for papers by Aivars Lejnieks Breakdown of academic impact, for papers by Danyal Imani
Rankless by CCL
2026